275 related articles for article (PubMed ID: 28506209)
1. Peptides mimicking viral proteins of porcine circovirus type 2 were profiled by the spectrum of mouse anti-PCV2 antibodies.
Hung LC; Yang CY; Cheng IC
BMC Immunol; 2017 May; 18(1):25. PubMed ID: 28506209
[TBL] [Abstract][Full Text] [Related]
2. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
[TBL] [Abstract][Full Text] [Related]
3. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
4. Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs.
Santos MR; Assao VS; Santos FAA; Salgado RL; Carneiro AP; Fietto JLR; Bressan GC; de Almeida MR; Lobato ZIP; Ueira-Veira C; Goulart LR; Silva-Júnior A
Arch Virol; 2018 Jul; 163(7):1877-1887. PubMed ID: 29589172
[TBL] [Abstract][Full Text] [Related]
5. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
[TBL] [Abstract][Full Text] [Related]
6. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
7. Selection and identification of single-domain antibody fragment against capsid protein of porcine circovirus type 2 (PCV2) from C. bactrianus.
Yang S; Shang Y; Yin S; Tian H; Chen Y; Sun S; Jin Y; Liu X
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):12-9. PubMed ID: 24736187
[TBL] [Abstract][Full Text] [Related]
8. High-level expression and immunogenicity of porcine circovirus type 2b capsid protein without nuclear localization signal expressed in Hansenula polymorpha.
Xiao Y; Zhao P; Du J; Li X; Lu W; Hao X; Dong B; Yu Y; Wang L
Biologicals; 2018 Jan; 51():18-24. PubMed ID: 29225046
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of a DNA vaccine encoding capsid protein of porcine circovirus-like virus P1 against porcine circovirus 2 in mice.
Zhang D; He K; Wen L; Fan H
Microbiol Immunol; 2018 Mar; 62(3):195-199. PubMed ID: 29315776
[TBL] [Abstract][Full Text] [Related]
10. Carboxyl-Terminal Decoy Epitopes in the Capsid Protein of Porcine Circovirus Type 2 Are Immunogenicity-Enhancers That Elicit Predominantly Specific Antibodies in Non-Vaccinated Pigs.
Hung LC
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366471
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
[TBL] [Abstract][Full Text] [Related]
12. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
[TBL] [Abstract][Full Text] [Related]
13. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
15. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice.
Liu X; Ouyang T; Ma T; Ouyang H; Pang D; Ren L
BMC Vet Res; 2018 Apr; 14(1):137. PubMed ID: 29685143
[TBL] [Abstract][Full Text] [Related]
18. Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope.
Mo X; Li X; Yin B; Deng J; Tian K; Yuan A
PLoS Pathog; 2019 Mar; 15(3):e1007562. PubMed ID: 30822338
[TBL] [Abstract][Full Text] [Related]
19. Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease.
Trible BR; Kerrigan M; Crossland N; Potter M; Faaberg K; Hesse R; Rowland RR
Clin Vaccine Immunol; 2011 May; 18(5):749-57. PubMed ID: 21430122
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2.
Shang SB; Jin YL; Jiang XT; Zhou JY; Zhang X; Xing G; He JL; Yan Y
Mol Immunol; 2009 Jan; 46(3):327-34. PubMed ID: 19059648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
